Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
JAVELIN Renal 101试验的最新疗效结果：一线avelumab联合axitinib对比舒尼替尼治疗晚期肾细胞癌患者
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2020.04.010
Choueiri, T K; Motzer, R J; Rini, B I; Haanen, J; Campbell, M T; Venugopal, B; Kollmannsberger, C; Gravis-Mescam, G; Uemura, M; Lee, J L; Grimm, M-O; Gurney, H; Schmidinger, M; Larkin, J; Atkins, M B; Pal, S K; Wang, J; Mariani, M; Krishnaswami, S; Cislo, P; Chudnovsky, A; Fowst, C; Huang, B; di Pietro, A; Albiges, L
